ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08485
-0,05%
Bitcoin
69.112,21
0,85%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Sorrento Therapeutics Inc (SRNE)

  7. Sorrento Therapeutics Inc (SRNE) News

SRNE

Sorrento Therapeutics (SRNE)

Sorrento Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SRNE
DatumZeitQuelleÜberschriftSymbolFirma
03/11/202322h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
27/10/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
13/09/202303h51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
28/08/202323h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
07/08/202322h15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:SRNESorrento Therapeutics Inc
01/08/202312h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
13/07/202312h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
21/06/202323h25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRNESorrento Therapeutics Inc
20/06/202323h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
15/06/202315h44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
05/06/202315h00GlobeNewswire Inc.Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the ANASDAQ:SRNESorrento Therapeutics Inc
19/05/202312h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
15/05/202321h18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SRNESorrento Therapeutics Inc
15/05/202318h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
12/05/202323h29Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRNESorrento Therapeutics Inc
09/05/202312h03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SRNESorrento Therapeutics Inc
03/05/202312h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
20/04/202323h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
20/04/202318h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
12/04/202314h51Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SRNESorrento Therapeutics Inc
10/04/202323h23Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SRNESorrento Therapeutics Inc
10/04/202321h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
31/03/202312h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
21/03/202300h54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRNESorrento Therapeutics Inc
20/03/202311h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
10/03/202317h22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRNESorrento Therapeutics Inc
08/03/202320h20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRNESorrento Therapeutics Inc
22/02/202315h25AllPennyStocks.comBankruptcy Court Approval Causes Premarket Buying PressureNASDAQ:SRNESorrento Therapeutics Inc
21/02/202323h57PR Newswire (US)Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 CaseNASDAQ:SRNESorrento Therapeutics Inc
21/02/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SRNE

Kürzlich von Ihnen besucht

TSX
ATCU
Alta Copper
BOV
PRIO3F
PETRORIO ON
EU
BE0002922038
Wallonne 3250% until 06/...
NASDAQ
FRWAU
PWP Forward Acquisition ...
LSE
GLOW
Sp Stox Gi L
AQSE
LPLA.GB
WisdomTree Commodity Sec...
BIT
S28685
Societe Generale Effekten
EU
CYBE
iShares China CNY Bond U...
USOTC
LMDXF
LumiraDx (PK)
LSE
IEXF
Ishr E C X-f
BIT
F17969
Vontobel Financial Produ...
BIT
S29760
Societe Generale Effekten
NASDAQ
FXRNBX
Skybridge Digital Innova...
NASDAQ
AEPIX
Allspring Managed Accoun...
COIN
ACNBTC
NASDAQ
SELB
Selecta Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten